- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-TSC22D1
TSC22D1 Polyclonal Antibody for WB, IHC, IF/ICC, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat et plus (1)
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 10214-1-Ig
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | tissu cérébral humain, cellules A549, tissu cérébral de rat |
| Résultats positifs en IP | tissu cérébral de rat |
| Résultats positifs en IHC | tissu cérébral humain, tissu testiculaire humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
| Résultats positifs en IF/ICC | cellules A549, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochimie (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 4 publications below |
| WB | See 9 publications below |
| IHC | See 2 publications below |
| IF | See 2 publications below |
| IP | See 2 publications below |
Informations sur le produit
10214-1-Ig cible TSC22D1 dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, rat
| Réactivité | Humain, rat |
| Réactivité citée | Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | TSC22D1 Protéine recombinante Ag0287 |
| Nom complet | TSC22 domain family, member 1 |
| Masse moléculaire calculée | 16 kDa |
| Poids moléculaire observé | 16 kDa |
| Numéro d’acquisition GenBank | BC000456 |
| Symbole du gène | TSC22D1 |
| Identification du gène (NCBI) | 8848 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine A |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
TSC22 domain family 1, transforming growth factor beta 1 induced transcript 4, (TSC22D1, synonyms: TSC22, TGFB1I4, MGC17597) is a member of a family of leucine zipper containing transcription factors with repressor activity and belongs to the large family of early response genes. TSC-22 regulates cell growth and differentiation, and cell death. Leucine zipper structure of TSC22 inhibits the anchorage independent growth of cancer cells. TSC-22 is also an important downstream component of peroxisome proliferator-activated receptor (PPAR) and TGF-beta signaling during intestinal epithelial cell differentiation. This antibody is a rabbit polyclonal antibody raised against an internal region of human TSC22D1.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for TSC22D1 antibody 10214-1-Ig | Download protocol |
| IHC protocol for TSC22D1 antibody 10214-1-Ig | Download protocol |
| IF protocol for TSC22D1 antibody 10214-1-Ig | Download protocol |
| IP protocol for TSC22D1 antibody 10214-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Cell Death Differ TSC-22D1 isoforms have opposing roles in mammary epithelial cell survival. | ||
Clin Cancer Res Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition.
| ||
Int J Mol Sci Identification of Binding Proteins for TSC22D1 Family Proteins Using Mass Spectrometry. | ||
FEBS J Multiple TSC22D4 iso-/phospho-glycoforms display idiosyncratic subcellular localizations and interacting protein partners. | ||
Am J Physiol Heart Circ Physiol Transforming growth factor-beta1 regulation of C-type natriuretic peptide expression in human vascular smooth muscle cells: dependence on TSC22D1. | ||
Biochem Biophys Res Commun Low levels of TSC22 enhance tumorigenesis by inducing cell proliferation in colorectal cancer. |










